K Frischmuth Selected Research

C-Reactive Protein

4/2006

Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Frischmuth Research Topics

Disease

2	Neoplasms (Cancer) 01/2001 - 03/2000
1	Necrosis 04/2006
1	Pain (Aches) 04/2006
1	Psoriatic Arthritis 04/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2001
1	Uterine Cervical Dysplasia 01/2001
1	Vulvar Neoplasms (Vulvar Cancer) 03/2000

Drug/Important Bio-Agent (IBA)

1	C-Reactive ProteinIBA 04/2006
1	Cartilage Oligomeric Matrix ProteinIBA 04/2006
1	Infliximab (Remicade)FDA Link 04/2006
1	Biomarkers (Surrogate Marker)IBA 04/2006
1	Proteins (Proteins, Gene)FDA Link 01/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2001
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2001
1	angiogeninIBA 01/2001
1	Tissue Polypeptide AntigenIBA 03/2000
1	Tumor Biomarkers (Tumor Markers)IBA 03/2000
1	Keratins (Keratin)IBA 03/2000

Therapy/Procedure

2	Therapeutics 04/2006 - 03/2000